Home Healthcare Biotechnology Intravenous Immunoglobulin Market

Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Immunodeficiency Diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR2187DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Intravenous Immunoglobulin Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Hypogammaglobulinemia
    2. CIDP
    3. Immunodeficiency Diseases
    4. Congenital AIDS
    5. Chronic Lymphocytic Leukemia
    6. Myasthenia Gravis
    7. Multifocal Motor Neuropathy
    8. ITP
    9. Kawasaki Disease
    10. Guillain-Barre Syndrome
  2. Intravenous Immunoglobulin Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacy
    2. Specialty Pharmacy
  3. Regional Intravenous Immunoglobulin Market
    1. North America
      1. North America Intravenous Immunoglobulin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      2. North America Intravenous Immunoglobulin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
      3. U.S.
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      4. Canada
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
    2. Europe
      1. Europe Intravenous Immunoglobulin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      2. Europe Intravenous Immunoglobulin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
      3. U.K.
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      4. Germany
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      5. France
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      6. Spain
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      7. Italy
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      8. Russia
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      9. Nordic
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      10. Benelux
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      11. Rest of Europe
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
    3. APAC
      1. APAC Intravenous Immunoglobulin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      2. APAC Intravenous Immunoglobulin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
      3. China
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      4. Korea
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      5. Japan
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      6. India
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      7. Australia
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      8. Taiwan
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      9. South East Asia
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      10. Rest of Asia-Pacific
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
    4. Middle East and Africa
      1. Middle East and Africa Intravenous Immunoglobulin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      2. Middle East and Africa Intravenous Immunoglobulin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
      3. UAE
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      4. Turkey
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      5. Saudi Arabia
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      6. South Africa
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      7. Egypt
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      8. Nigeria
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      9. Rest of MEA
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
    5. LATAM
      1. LATAM Intravenous Immunoglobulin Market By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      2. LATAM Intravenous Immunoglobulin Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
      3. Brazil
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      4. Mexico
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      5. Argentina
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      6. Chile
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      7. Colombia
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
      8. Rest of LATAM
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
        11. Hospital Pharmacy
        12. Specialty Pharmacy
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.